EVERSANA™ is the leading independent provider of global life science services, offering patient-centered solutions across the product lifecycle.
Since 1994, EVERSANA has helped tissue and medical device companies meet complex regulatory and quality requirements. In partnership with Reprotech, EVERSANA developed the Electronic Donor Eligibility System (DES)—a web-based tool that streamlines donor screening, review, and testing.
DES supports compliance with FDA 21 CFR 1271, enables remote access and approvals, and improves speed, efficiency, and cost savings. For more information about the EVERSANA and Reprotech Donor Eligibility System, please contact EVERSANA at info@eversana.com.
EVERSANA™ is the leading independent provider of global life science services, offering patient-centered solutions across the product lifecycle.
Since 1994, EVERSANA has helped tissue and medical device companies meet complex regulatory and quality requirements. In partnership with Reprotech, EVERSANA developed the Electronic Donor Eligibility System (DES)—a web-based tool that streamlines donor screening, review, and testing.
DES supports compliance with FDA 21 CFR 1271, enables remote access and approvals, and improves speed, efficiency, and cost savings. For more information about the EVERSANA and Reprotech Donor Eligibility System, please contact EVERSANA at info@eversana.com.
